Tag Archives: laboratory

Deadly Virus Flew From Canada To China On Commercial Flight

Minister Says He Was Taken Aback After Learning Deadly Viruses Were Shipped From Winnipeg Lab to Wuhan

Report first published via friends at The Epoch Times

Minister Says He Was Taken Aback After Learning Deadly Viruses Were Shipped From Winnipeg Lab to Wuhan
Canada Minister of Public Safety Dominic LeBlanc speaks in the Foyer of the House of Commons on Parliament Hill in Ottawa, on March 20, 2024. (The Canadian Press/Spencer Colby)

After learning that samples of deadly Ebola and Nipah viruses had been sent from Canada’s top-security lab in Winnipeg to China, Public Safety Minister Dominic LeBlanc said his reaction was similar to that of an MP who expressed incredulity upon learning of the move.

“I’m really concerned about the March 2019 incident where [Winnipeg lab scientists Xiangguo Qiu and Keding Cheng] were implicated in a shipment of live Ebola in Hanipah [Nipah] viruses on a commercial Air Canada flight. How the hell did that happen?” NDP MP Charlie Angus asked during a House of Commons Canada-China committee meeting on April 15.

In response, Mr. LeBlanc said, “When I saw that report, and publicly, I had the same reaction as you.”

A partly redacted national memo sent by the prime minister’s national security advisor to Prime Minister Justin Trudeau on June 29, 2017.

The minister deferred Mr. Angus’ question to the Public Health Agency of Canada, saying, “I don’t have any [information], but I had the same reaction as you, Mr. Angus.”

Mr. LeBlanc, who became minister of public safety in July 2023, was previously minister of intergovernmental affairs starting in July 2018.

The National Microbiology Laboratory (NML) in Winnipeg shipped 15 different strains of Nipah and Ebola viruses to the Wuhan Institute of Virology (WIV) in China on March 31, 2019. The package was sent from Winnipeg to Toronto and then on to Beijing via a commercial Air Canada flight.

Timeline: What Declassified Documents Reveal About the Fired Winnipeg Lab Scientists

Ms. Qiu and Mr. Cheng

The request to the NML management for the shipment of the viruses was facilitated by Ms. Qiu. The shipment was eventually approved by the NML management.

Ms. Qiu and Mr. Cheng, a married couple, were escorted out of the NML in July 2019 while under RCMP investigation. The couple were fired from their positions on Jan. 20, 2021, for having undisclosed ties to Chinese regime entities.

In 2021, in response to MPs’ questions about why the NML shipped virus samples to the Wuhan lab, laboratory management said the shipment followed all proper protocols and was in response to a letter from the Chinese lab indicating that they were to be used to understand their pathophysiology—the nature of infection—and the development of antivirals.

Declassified intelligence documents show that Ms. Qiu also sent antibodies and other materials to China without prior approval.

Shipments included antibodies for the China National Institute for Food and Drug Control, as well as small amounts sent to laboratories in the United Kingdom and the United States for testing.

The documents show that Ms. Qiu discussed the shipment of Ebola and Nipah with WIV employees in July 2018, and initially suggested that a formal agreement is not necessary as “no one owns the IP.” She also expressed “hope there is another way around” rather than issuing a formal agreement.

The documents also show that Ms. Qiu signed on to a project at WIV involving research on Ebola, and that some of the virus strains that were shipped from NML were meant for this project. Ms. Qiu had asked that the project remain a secret to her Canadian management as WIV was in the process of requesting the transfer of the virus strains from NML, the documents say.

Researchers work in the National Microbiology Laboratory in Winnipeg, Man., where the ZMapp antibody “cocktail” was created to fight Ebola. PHOTO BY HANDOUT

The Wuhan lab has been involved in synthetic biology research on the deadly Nipah virus, according to testimony from a U.S. scientist. Synthetic biology involves creating or redesigning biological entities and systems.

“The Nipah virus is a smaller virus than SARS2 [the virus causing COVID-19] and is much less transmissible,” Dr. Steven Quay, a Seattle-based physician-scientist, told a U.S. Senate subcommittee hearing on Aug. 3, 2022. “But it is one of the deadliest viruses, with a greater than 60 percent lethality” and 60 times deadlier than SARS2, he said. “This is the most dangerous research I have ever encountered.”

Chinese Talent Recruitment

During the April 15 House committee meeting, Mr. LeBlanc acknowledged revelations from the declassified documents that Ms. Qiu was involved in China’s Thousand Talents Program. The program was recognized by U.S. authorities as China’s efforts to “incentivize its members to steal foreign technologies needed to advance China’s national, military, and economic goals.”

It is clear that “elements from a Chinese-sponsored recruitment program were involved” at the Winnipeg lab, Mr. LeBlanc said. “It is well known that such programs are one way that China seeks to incentivize academics to participate in activities that exploit advancements in Canadian technologies.”

China is using the programs “to improve its military and intelligence capabilities, as well as the economic competitiveness all at the expense of Canada’s national interest,” the minister said.

He declined to address concerns raised by Conservative MP Michael Cooper regarding the delay in removing Ms. Qiu from the NML, saying it should be addressed to the health minister whose department is in charge of the Public Health Agency of Canada, which in turn oversees the NML.

Although concerns about the two were first raised in 2018, they weren’t fired until three years later. For The Silo, Andrew Chen. Omid Ghoreishi and Noé Chartier contributed to this report

Supplemental– Bio-warfare experts question why Canada was sending lethal viruses to China.

Supplemental- Canada sent untested ebola vaccine to World Health Organization.

Whole City COVID Testing Will Begin In Liverpool UK

Pasadena, Calif. (November, 2020) – Innova Medical Group, Inc. (IMG) has partnered with the UK Government in its roll out of whole city screening and testing, beginning in Liverpool, with its INNOVA SARS-CoV-2 Antigen Rapid Qualitative Test Kits. 

Innova Medical’s lateral flow antigen test uses nasal and throat swab samples to screen for infection, with highly accurate results in as little as 15-minutes. This test can be easily and safely administered anywhere, on both asymptomatic and symptomatic people, without costly delays and the need for a full-scale laboratory. With its low cost per test, about the same as a coffee and biscuit in London, at-risk populations and many with inequitable access to healthcare, can achieve peace-of-mind with a negative result. U.K. Government data showed the IMG rapid SARS-CoV-2 antigen test screened asymptomatic individuals with 98.98 percent accuracy.

https://youtu.be/S2qRibNrBPs

Dr. Susan Hopkins, Incident Director at Public Health England, said, “The tests we are using in Liverpool are accurate, especially in finding people who are infectious at that moment in time and so are more likely to pass it on to others. Part of the purpose of working with Liverpool to roll out whole city testing is to better understand how these tests work in the field, improve understanding of why people get tested, and the impact of this approach on reducing the transmission rate.”

Using the National Health Service (NHS COVID-19) app, people can book a test and later input their test results.

Individuals taking part in the roll out of Operation Moonshot will be notified of positive or negative results by text or email. With this important test-and-trace system in place, public health authorities can diagnose cases, isolate infected patients, trace their contacts, and implement stringent infection control policies to reduce outbreaks.

With colder months and the holiday season ahead, the risk of virus transmission accelerates with more indoor gatherings and travel. If people do not know they have COVID-19, it is unlikely they will take precautions to prevent virus spread. Research studies show that to achieve disease control both asymptomatic, people who are infected but never develop symptoms, and pre-symptomatic, infected people who develop symptoms later, must be isolated.

Under Operation Moonshot, the UK Government hopes to flatten the curve by employing proactive, rather than reactive, measures in its COVID-19 response. Up to 1-in-5 United Kingdom coronavirus infections present with no symptoms, but they are still contagious. The Centers for Disease Control and Prevention (CDC) says up to 40 percent of infected people are asymptomatic and should be tested if they have been exposed. Typically, a person develops symptoms 5 days after being infected; however, infectivity was found to be highest a day before symptom onset. After symptoms, such as a cough, fever, and shortness of breath, first appear, a person can remain contagious for at least ten days.

The Innova Rapid Antigen Test quickly identifies infectiousness. The lateral flow test can identify people with a high viral load who are the most likely to spread the virus. Daniel Elliott, President of Innova Medical Group, Inc., said, “Our lateral flow device incorporates a German nitrocellulose membrane partially composed of nanoparticles of colloidal gold. [ Colloidal gold is nanoparticles of gold in a liquid solution. These gold nanoparticles are coated in such a way that they detect Covid antibodies. CP ] This advanced, proprietary technology combined with our room temperature reagent, allows testing at point-of-care settings such as workplaces, universities, and airports.”

GLOBAL SUPPLY CHAIN AND PRODUCTION

Innova Medical Group Inc. offers a global supply chain including the innovative and respected firms, GE Healthcare (USA) and Sartorius (Germany). IMG secured exclusive manufacturing and distribution agreements for its best-in-class portfolio of screening and diagnostic tests. By the end of November 2020, IMG will produce millions of kits per day in its Brea, California plant, combined with activity from plants in other global locations. After being selected over a large number of submissions to take part in Operation Moonshot, IMG is also exploring options for production in the United Kingdom.

The Innova test carries a CE Marking indicating that this IVD device complies with the European In-Vitro Diagnostic Devices Directive (98/79/EC). This device may be legally commercialized in the European Union (EU). For the Silo, Julie R. Manley.

About Innova Medical Group

Innova Medical Group, Inc. (IMG), is a wholly-owned subsidiary of Pasaca Capital (Pasadena, Calif.). IMG strategically pivoted and leveraged its expertise in Healthcare and Medical Devices to create an ecosystem to respond to the COVID-19 pandemic. The Innova Medical Ecosystem is delivering millions of tests every day to satisfy the diverse, point-of-care requirements of the world’s governments, large corporations, and institutions. IMG offers a global supply chain including the innovative and respected firms, GE Healthcare (USA), and Sartorius (Germany). IMG secured exclusive manufacturing and distribution agreements for its best-in-class portfolio of screening and diagnostic tests. For more information, visit www.innovamedgroup.com.